Adherence in clinical trials and in clinical practice
Walsh, J.C.
Antiviral Therapy 4(Suppl 3): 49-54
1999
ISSN/ISBN: 1359-6535 PMID: 16021871 Document Number: 505932
The degree of patient adherence is increasingly recognized to be a key factor in the success of highly active antiretroviral therapy (HAART). HAART regimens are also among the most complex ever prescribed and low adherence is directly related to treatment complexity. Physicians prescribing HAART need to make adherence a priority both in clinical practice and in the design and interpretation of clinical trials if HAART really is to succeed in the long term.
Document emailed within 1 workday
Related Documents
Sumari-de Boer, I.M.; Ngowi, K.M.; Swai, I.U.; Masika, L.V.; Maro, R.A.; Mtenga, A.E.; Mtesha, B.A.; Nieuwkerk, P.T.; Reis, R.; de Wit, T.F.R.; Aarnoutse, R.E. 2023: Effect of a customized digital adherence tool on retention in care and adherence to antiretroviral treatment in breastfeeding women, children and adolescents living with HIV in Tanzania: a mixed-methods study followed by clinical trials Trials 24(1): 285Feriani, M. 1997: Bicarbonate-buffered CAPD solutions: from clinical trials to clinical practice Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 17(Suppl 2): S51-S55
Hyrich, K.L.; Symmons, D.P.M.; Silman, A.J. 2005: Reconciling subject differences in recruitment to clinical trials and clinical practice Journal of Rheumatology 32(12): 2475-2476
Ryan, M.E. 2002: Host modulation: conceptualization to clinical trials and integration into clinical practice Journal of the California Dental Association 30(4): 285-288; 290-295
Latib, A.; Costopoulos, C.; Naganuma, T.; Colombo, A. 2013: Which patients could benefit the most from bioresorbable vascular scaffold implant: from clinical trials to clinical practice Minerva Cardioangiologica 61(3): 255-262
Brotons, C.; Moral, I.; Antón, J.J.; Cobos, M.; Cucurull, E.; Gállego, C.; Ibáñez, M.; Pérez, A.; Llussà, J.; Orozco, P.; Ventureira, S.; Samarra, M.; Sanz, J.; Permanyer, G.; López, A. 1997: Preventive treatment of nonrheumatic atrial fibrillation: from the efficacy of clinical trials to the effectiveness of clinical practice Atencion Primaria 20(7): 367-371
Kvien, T.K.; Mikkelsen, K.; Nordvåg, B.ør.-Y. 2003: Results from controlled clinical trials: how relevant for clinical practice? Journal of Rheumatology 30(6): 1135-1137
Richman, D.; Itri, L.; Johnson, M.F.; Eigo, J. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence) trials Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S88
Eisenach, J.C. 1996: New agents to clinical practice: introduction to clinical trials Regional Anesthesia 21(6 Suppl): 135-136
Savonitto, S.; Klugmann, S. 2004: Acute coronary syndromes without ST-segment elevation. From randomized clinical trials, to consensus guidelines, to clinical practice in Italy: need to close the circle Italian Heart Journal. Supplement: Official Journal of the Italian Federation of Cardiology 5(3): 167-176
Lietman, P.; Temple, R.; Harrington, M.; Peck, C. 1990: Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--approaches to clinical trials design Journal of Acquired Immune Deficiency Syndromes 3 Suppl. 2: S27
Shimoyama, M.; Tajima, K. 1993: Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(16): 2507-2518
Dancey, J.E.; Schoenfeldt, M. 2003: Clinical trials referral resource. Current clinical trials of agents targeting epidermal growth factor receptor Oncology 17(6): 819; 826
Davis, T.; Gore-Langton, R.E.; Cheson, B.D. 2000: Clinical trials referral resource. Current clinical trials of the anti-CD20 monoclonal antibody rituximab Oncology 14(10): 1437; 1440-1443
Baldini, C.; Delle Sedie, A.; Bombardieri, S. 2005: From clinical trials to the bedside: how can we treat patients with rheumatoid arthritis and concurrent morbidities who are generally excluded from randomised controlled clinical trials? Clinical and Experimental Rheumatology 23(6): 893-904
Trimble, E.L.; Rowland, J.; Varricchio, C.; Gore-Langton, R.E. 2001: Clinical trials referral resource. Health-related quality of life in cancer clinical trials Oncology 15(5): 601
Davis, T.; Schoenfeldt, M. 2004: Clinical trials referral resource. Current phase IIi clinical trials for adults with leukemia or lymphoma Oncology 18(1): 62; 65, 69
Saxman, S.B.; West, P.J.; Cheson, B.D. 2001: Clinical trials referral resource. Current clinical trials in small-cell lung cancer Oncology 15(3): 318-319; 323
Weigmann, K. 2015: The ethics of global clinical trials: in developing countries, participation in clinical trials is sometimes the only way to access medical treatment. what should be done to avoid exploitation of disadvantaged populations? Embo Reports 16(5): 566-570
Boissel, J.P. 1989: Subcommittee on Clinical Trials. Registry of multicenter clinical trials. Tenth report--1988 Thrombosis and Haemostasis 62(4): 1126-1142